 - Patients with baseline funduscopic evidence of active proliferative diabetic retinopathy, preproliferative diabetic retinopathy, or wet AMD ANDOR Patients with a history of treatment for active proliferative diabetic retinopathy or wet AMD within 5 years of enrollment. 